Lannett launches generic AggrenoxAspirin and extended-release dipyridamole capsules had a market value of roughly $158 million for the 12 months ended April 2019, according to IQVIA, although actual generic market values are expected to be lower. SC Johnson acquires Sun BumS.C. Johnson announced that it will acquire Sun Bum, which creates products in the sun protection, hair care and lip care categories, as well as Baby Bum. Lilly to acquire non-opioid pain asset from Centrexion Therapeutics CNTX-0290 is being studied as a non-opioid treatment for chronic pain conditions. Blink Health opens new office in Pittsburgh Blink Health, which already has offices in New York, Boston, and St. Louis, is opening its doors in Pittsburgh. Dr. Reddy’s to sell neurology branded products to Upsher-Smith Dr. Reddy’s is selling the U.S. and select territory rights for Zembrace Symtouch and Tosymra to Upsher-Smith Labs for an upfront price of $70 million and $40.5 million in milestone and other considerations. Amgen, Allergan get FDA nod for biosimilar Herceptin The FDA approval of biosimilar Herceptin provides an additional treatment option for patients across three types of cancer. Walmart merging Jet.com into its digital business Walmart is merging Jet.com’s retail, technology, marketing, analytics and products teams into the rest of its digital business. Merck to acquire Tilos Therapeutics Tilos Therapeutics develops products for the treatment of cancer, fibrosis and autoimmune diseases. Tatcha to become part of the Unilever family Unilever has signed an agreement to acquire skin care brand Tatcha. CutisPharma renames to Azurity Pharmaceuticals alongside Silvergate acquisition Azurity Pharmaceuticals, formed by CutisPharma's acquisition of Silvergate, has 12 products serving multiple therapeutic areas. First Previous 133 134 135 136 137 Next Last
